Canopy-2: Phase 3 Study Of Canakinumab Plus Docetaxel As Second/Third Line Therapy In Locally Advanced/Metastatic NsclcM Reck,L Paz-Ares,Y Goto,D Lim,VA Papadimitrakopoulou,B Mookerjee,I Malet,Z ZewenPNEUMOLOGIE（2020）引用 0|浏览28暂无评分关键词canakinumab,second/third line therapyAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
